Search Results

You are looking at 1 - 2 of 2 items for

  • Author: Jie Sun x
Clear All Modify Search
Mengxue Yang Department of Endocrinology, The Fifth People’s Hospital of Shanghai, Fudan University, Shanghai, China
Department of Endocrinology, Zunyi Medical University, Zunyi, China

Search for other papers by Mengxue Yang in
Google Scholar
PubMed
Close
,
Bowen Sun Department of Endocrinology, Zunyi Medical University, Zunyi, China

Search for other papers by Bowen Sun in
Google Scholar
PubMed
Close
,
Jianhui Li Department of Endocrinology, Ningbo No. 2 Hospital, Ningbo, China

Search for other papers by Jianhui Li in
Google Scholar
PubMed
Close
,
Bo Yang Department of Endocrinology, Zunyi Medical University, Zunyi, China

Search for other papers by Bo Yang in
Google Scholar
PubMed
Close
,
Jie Xu School of Public Health, Zunyi Medical University, Zunyi, China

Search for other papers by Jie Xu in
Google Scholar
PubMed
Close
,
Xue Zhou Department of Endocrinology, Zunyi Medical University, Zunyi, China

Search for other papers by Xue Zhou in
Google Scholar
PubMed
Close
,
Jie Yu School of Public Health, Zunyi Medical University, Zunyi, China

Search for other papers by Jie Yu in
Google Scholar
PubMed
Close
,
Xuan Zhang Department of Endocrinology, Zunyi Medical University, Zunyi, China

Search for other papers by Xuan Zhang in
Google Scholar
PubMed
Close
,
Qun Zhang Department of Endocrinology, Ningbo No. 2 Hospital, Ningbo, China

Search for other papers by Qun Zhang in
Google Scholar
PubMed
Close
,
Shan Zhou Department of Endocrinology, Ningbo No. 2 Hospital, Ningbo, China

Search for other papers by Shan Zhou in
Google Scholar
PubMed
Close
, and
Xiaohua Sun Department of Endocrinology, Ningbo No. 2 Hospital, Ningbo, China

Search for other papers by Xiaohua Sun in
Google Scholar
PubMed
Close

Objectives

The pathogenesis of Graves’ disease (GD) remains unclear. In terms of environmental factors, GD development may be associated with chronic inflammation caused by alteration of the intestinal flora. This study explored the association of intestinal flora alteration with the development of GD among the Han population in southwest China.

Design and methods

Fifteen GD patients at the Affiliated Hospital of Zunyi Medical College between March 2016 and March 2017 were randomly enrolled. Additionally, 15 sex- and age-matched healthy volunteers were selected as the control group during the same period. Fresh stool samples were collected, and bacterial 16S RNA was extracted and amplified for gene sequencing with the Illumina MiSeq platform. The sequencing results were subjected to operational taxonomic unit-based classification, classification verification, alpha diversity analysis, taxonomic composition analysis and partial least squares-discriminant analysis (PLS-DA).

Results

The diversity indices for the GD group were lower than those for the control group. The GD group showed significantly higher abundances of Firmicutes, Proteobacteria and Actinobacillus and a higher Firmicutes/Bacteroidetes ratio than the control group. PLS-DA suggested the satisfactory classification of the flora between the GD group and the control group. The abundances of the genera Oribacterium, Mogibacterium, Lactobacillus, Aggregatibacter and Mogibacterium were significantly higher in the GD group than in the control group (P < 0.05).

Conclusions

The intestinal flora of GD patients was significantly different from that of the healthy population. Thus, alteration of intestinal flora may be associated with the development of GD.

Open access
Qi Zhang Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Qi Zhang in
Google Scholar
PubMed
Close
,
Hongshan Wang Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Hongshan Wang in
Google Scholar
PubMed
Close
,
Yanhong Xie Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Yanhong Xie in
Google Scholar
PubMed
Close
,
Suming Huang Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Suming Huang in
Google Scholar
PubMed
Close
,
Ke Chen Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Ke Chen in
Google Scholar
PubMed
Close
,
Botian Ye Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Botian Ye in
Google Scholar
PubMed
Close
,
Yupeng Yang Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Yupeng Yang in
Google Scholar
PubMed
Close
,
Jie Sun Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Jie Sun in
Google Scholar
PubMed
Close
,
Hongyong He Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Hongyong He in
Google Scholar
PubMed
Close
,
Fenglin Liu Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Fenglin Liu in
Google Scholar
PubMed
Close
,
Zhenbin Shen Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Zhenbin Shen in
Google Scholar
PubMed
Close
,
Weidong Chen Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Weidong Chen in
Google Scholar
PubMed
Close
,
Kuntang Shen Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Kuntang Shen in
Google Scholar
PubMed
Close
,
Yuan Ji Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Yuan Ji in
Google Scholar
PubMed
Close
, and
Yihong Sun Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Yihong Sun in
Google Scholar
PubMed
Close

A new subcategory, grade 3 neuroendocrine tumors, is incorporated into the grading system of pancreatic neuroendocrine neoplasms in the 2017 WHO classification in order to differentiate grade 3 neuroendocrine tumors from neuroendocrine carcinomas. The 2019 WHO classification extends the concept of grade 3 neuroendocrine tumors to gastrointestinal high-grade neuroendocrine neoplasms. However, there is still limited study focusing on the gastric grade 3 neuroendocrine tumors and gastric neuroendocrine carcinomas. We retrospectively enrolled 151 gastric high-grade neuroendocrine neoplasms patients, who underwent radical resection from January 2007 to December 2015. Clinicopathologic and prognostic features were studied. The Surveillance, Epidemiology, and End Results (SEER) database was used to verify the prognostic determinants found in the Zhongshan cohort. Neuroendocrine carcinomas showed a higher Ki67 index and higher mitotic count than grade 3 neuroendocrine tumors. We identified 109 (72.2%) patients with neuroendocrine carcinomas, 12 (7.9%) patients with grade 3 neuroendocrine tumors, and 30 (19.9%) patients with mixed neuroendocrine-non-neuroendocrine neoplasms. Although neuroendocrine carcinomas demonstrated higher Ki67 index (P = 0.004) and mitoses (P = 0.001) than grade 3 neuroendocrine tumors, their prognosis after radical resection did not demonstrate significant differences (P = 0.709). Tumor size, perineural invasion, and TNM stage were independent prognostic factors of gastric high-grade neuroendocrine neoplasms.

Open access